- Money flow into biotech has turned decidedly positive. The iShares Nasdaq Biotechnology ETF (IBB +3%) has rallied almost 8% since Friday.
- Key drivers appear to be reduced anxiety over drug prices with the GOP's rebooted healthcare plan and President Trump's expected executive order, looming M&A deals and expectations of bullish Q1 results from Big Biopharma.
- Selected tickers: BIB XBI PFE MRK BMY NVS LLY JNJ AGN AMGN BIIB VRTX GILD CELG NVS ABBV